NorthCrest Asset Manangement’s BioLife Solutions BLFS Stock Holding History

NorthCrest Asset Manangement’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$420K	Buy	14,876 +33	+0.2%	+$771	0.01%	614
2026 Q1	$290K	Sell	14,843 -25	-0.2%	-$553	0.01%	629
2025 Q4	$376K	Sell	14,868 -20	-0.1%	-$523	0.01%	624
2025 Q3	$392K	Buy	14,888 +36	+0.2%	+$854	0.01%	555
2025 Q2	$339K	Buy	14,852 +134	+0.9%	+$3.02K	0.01%	493
2025 Q1	$336K	Buy	14,718 +18	+0.1%	+$474	0.01%	494
2024 Q4	$382K	Hold	14,700	–	–	0.01%	443
2024 Q3	$368K	Hold	14,700	–	–	0.01%	446
2024 Q2	$315K	Hold	14,700	–	–	0.01%	446
2024 Q1	$273K	Sell	14,700 -500	-3%	-$8.74K	0.01%	460
2023 Q4	$247K	Hold	15,200	–	–	0.01%	473
2023 Q3	$210K	Hold	15,200	–	–	0.01%	479
2023 Q2	$336K	Hold	15,200	–	–	0.01%	427
2023 Q1	$331K	Buy	15,200 +800	+6%	+$18K	0.01%	431
2022 Q4	$262K	Buy	14,400 +1,500	+12%	+$31K	0.01%	365
2022 Q3	$293K	Hold	12,900	–	–	0.02%	380
2022 Q2	$178K	Hold	12,900	–	–	0.01%	422
2022 Q1	$293K	Buy	+12,900	New	+$340K	0.01%	363

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NorthCrest Asset Manangement's BLFS Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its BioLife Solutions (BLFS) stake by 0.22% in Q2 2026, buying an estimated $771 and bringing the position to 14,876 shares worth $420K. The position accounts for 0.01% of the portfolio, ranked #614.

NorthCrest Asset Manangement first reported a position in BLFS in Q1 2022 and has held it in 18 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

NorthCrest Asset Manangement held 14,876 shares of BioLife Solutions worth $420K as of Q2 2026.
NorthCrest Asset Manangement bought 33 BioLife Solutions shares in Q2 2026, an estimated $771.
BioLife Solutions made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #614 holding.
NorthCrest Asset Manangement first reported a position in BioLife Solutions in Q1 2022 and has held it in 18 quarters since.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.